Target Price | $26.50 |
Price | $16.53 |
Potential |
60.31%
register free of charge
|
Number of Estimates | 2 |
2 Analysts have issued a price target Anika Therapeutics, Inc. 2025 .
The average Anika Therapeutics, Inc. target price is $26.50.
This is
60.31%
register free of charge
$28.00
69.39%
register free of charge
$25.00
51.24%
register free of charge
|
|
A rating was issued by 2 analysts: 2 Analysts recommend Anika Therapeutics, Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Anika Therapeutics, Inc. stock has an average upside potential 2025 of
60.31%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 166.66 | 150.20 |
6.67% | 9.88% | |
EBITDA Margin | 1.07% | 11.20% |
155.02% | 942.79% |
2 Analysts have issued a sales forecast Anika Therapeutics, Inc. 2024 . The average Anika Therapeutics, Inc. sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Anika Therapeutics, Inc. 2024 . The average Anika Therapeutics, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -5.64 | -2.63 |
452.94% | 53.37% | |
P/E | negative | |
EV/Sales | 1.38 |
2 Analysts have issued a Anika Therapeutics, Inc. forecast for earnings per share. The average Anika Therapeutics, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Anika Therapeutics, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Anika Therapeutics, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.